SCHEMBL9968476

SCHEMBL9968476

CC(=O)c1cc(S(=O)(=O)NCc2ccc(O)c(O)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
SLC12A2 P55011 1/20 0.47
SLC12A5 Q9H2X9 1/20 0.47
CYP19A1 P11511 4/20 0.45
VCAM1 P19320 2/20 0.45
MAPK1 P28482 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
SNCA P37840 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
HPGD P15428 2/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
CASP1 P29466 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968477 0.89 ALDH1A1 (0.43) ALDH1A1LMNAGAAMAPTSLC12A2
SCHEMBL9941200 0.82 POLB (0.59) ALDH1A1LMNAMAPTCYP1A2CYP3A4
SCHEMBL9968581 0.77 KDM4E (0.43) ALDH1A1LMNAMAPTCYP19A1MAPK1
SCHEMBL9968618 0.74 KMT2A (0.47) ALDH1A1LMNAMAPTCYP19A1MAPK1
SCHEMBL9942828 0.72 POLB (0.55) ALDH1A1LMNAMAPTCYP1A2CYP3A4
SCHEMBL9968569 0.69 MAPK1 (0.44) ALDH1A1LMNAMAPTMAPK1HPGD
SCHEMBL13497998 0.69 MAPT (0.49) ALDH1A1LMNAGAAMAPTCYP19A1
SCHEMBL13497999 0.69 MAPT (0.49) ALDH1A1MAPTCYP19A1CYP1A2CYP3A4
SCHEMBL6078727 0.68 CYP19A1 (0.50) LMNAMAPTCYP19A1CA2POLB
SCHEMBL15682651 0.68 KEAP1 (0.64) ALDH1A1LMNASLC12A2SLC12A5CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012082862-A2 ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2012-06-21 WO disclosed